Top 11 AIDS treatment startups

Oct 27, 2024 | By Jason Kwon

These startups develop new technologies to diagnose and treat AISD, such as gene editing technologies, long-acting antiretroviral therapies, point-of-care testing devices, viral load monitoring systems, mRNA vaccine platforms, nanotechnology for drug delivery.
1
Country: USA | Funding: $908.6M
Vir Biotechnology brings together cutting-edge innovations with scientific expertise and management.
2
Country: USA | Funding: $546.1M
Sangamo is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered zinc finger DNA-binding proteins (ZFPs) as novel ZFP Therapeutics targeting various monogenic and infectious diseases with unmet medical needs.
3
Country: USA | Funding: $115.9M
Nurx is offering Truvada as "PrEP," or an HIV preexposure prophylaxis. People looking to get on PrEP can sign up via Nurx's website or smartphone app.
4
Country: USA | Funding: $34.8M
Aethlon Medical creates immunotherapeutic devices to combat infectious disease and cancer.
5
Country: USA | Funding: $15.9M
We design transformational gene therapies that aim to enhance the body's own defenses to defeat disease.
6
Country: USA | Funding: $1.1M
Immunity Project is a Y Combinator-backed non profit organization. Immunity Project will offer the HIV vaccine to the world for free.
7
Country: France | Funding: €803K
Biosantech aims to promote and develop an effective vaccine on all variants of the AIDS virus.
8
Country: USA | Funding: $2.8M
We produce patient-friendly, affordable, accurate urine tests for the medication PrEP.
9
Country: Germany | Funding: €301.4K
ImmunoLogik has identified an active agent that helps patients who have developed a resistance against standard HIV treatment therapies.
10
Country: Israel
Vecoy Nanomedicines is a privately held company, is a leading company in the application of nanomedicine technologies to the complex issues of viral diseases. The Vecoy technology will fundamentally change the treatment of viral infections by administering novel nano-scale virus-traps that capture and destroy viruses.
Editor: Jason Kwon
Jason Kwon is a senior editor for MedicalStartups. He has previously covered the pharmaceutical and medical research industries for FDAnews and worked as a head of marketing for medical startup Sonic Therapeutics. Before that, he co-founded a startup consulting business for emerging entrepreneurial hubs in Asia. Jason graduated from St. Bonaventure University’s journalism school. In his free time, Jason enjoys yoga, watching movie trailers, traveling to places where he can't get cell service. You can contact Jason at jaskwon(at)medicalstartups(dot)com